SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Camila Oliveira de Souza, Mirian Ayumi Kurauti, Flaviane de Fatima Silva, Hely de Morais, Glaucia Regina Borba-Murad, Fábio Goulart de Andrade, Helenir Medri de Souza, Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats, Molecular and Cellular Biochemistry, 2015, 399, 1-2, 237

    CrossRef

  2. 2
    Stéphanie Chevalier, Samaneh Farsijani, Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment1,2, Applied Physiology, Nutrition, and Metabolism, 2014, 39, 6, 643

    CrossRef

  3. 3
    Patrizia Mondello, Michael Mian, Carmela Aloisi, Fausto Famà, Stefania Mondello, Vincenzo Pitini, Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options, Nutrition and Cancer, 2014, 1

    CrossRef

  4. 4
    Seyyed M. R. Kazemi-Bajestani, Harald Becher, Konrad Fassbender, Quincy Chu, Vickie E. Baracos, Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist, Journal of Cachexia, Sarcopenia and Muscle, 2014, 5, 2, 95

    CrossRef

  5. 5
    Cristina D'Orlando, Emanuele Marzetti, Stephanie François, Maria Lorenzi, Valentina Conti, Enrico Stasio, Fausto Rosa, Silvia Brunelli, Giovan Battista Doglietto, Fabio Pacelli, Maurizio Bossola, Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle, Muscle & Nerve, 2014, 49, 4
  6. 6
    Si-Zeng Chen, Jian-Dong Xiao, Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model, Tumor Biology, 2014, 35, 1, 323

    CrossRef

  7. 7
    Katja Trobec, Sandra Palus, Anika Tschirner, Stephan von Haehling, Wolfram Doehner, Mitja Lainscak, Stefan D. Anker, Jochen Springer, Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia, Nutrition, 2014, 30, 9, 1069

    CrossRef

  8. 8
    Patsie Polly, Timothy C. Tan, The role of vitamin D in skeletal and cardiac muscle function, Frontiers in Physiology, 2014, 5,

    CrossRef

  9. 9
    Fabio Penna, Domiziana Costamagna, Fabrizio Pin, Andrea Camperi, Alessandro Fanzani, Elena M. Chiarpotto, Gabriella Cavallini, Gabriella Bonelli, Francesco M. Baccino, Paola Costelli, Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia, The American Journal of Pathology, 2013, 182, 4, 1367

    CrossRef

  10. 10
    Maria Tsoli, Graham Robertson, Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem, Trends in Endocrinology & Metabolism, 2013, 24, 4, 174

    CrossRef

  11. 11
    Jvalini T. Dwarkasing, Miriam van Dijk, Francina J. Dijk, Mark V. Boekschoten, Joyce Faber, Josep M. Argilès, Alessandro Laviano, Michael Müller, Renger F. Witkamp, Klaske van Norren, Hypothalamic food intake regulation in a cancer-cachectic mouse model, Journal of Cachexia, Sarcopenia and Muscle, 2013,

    CrossRef

  12. 12
    Yang Quanjun, Yang Genjin, Wan Lili, Li Bin, Lu Jin, Yu Qi, Li Yan, Han Yonglong, Guo Cheng, Zhang Junping, Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice, Molecular BioSystems, 2013, 9, 12, 3015

    CrossRef

  13. 13
    Vickie E. Baracos, Evidence-Based Practice in Palliative Medicine, 2013,

    CrossRef

  14. 14
    Kenneth C.H. Fearon, David J. Glass, Denis C. Guttridge, Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways, Cell Metabolism, 2012, 16, 2, 153

    CrossRef

  15. 15
    M. L. Batista, R. X. Neves, S. B. Peres, A. S. Yamashita, C. S. Shida, S. R. Farmer, M. Seelaender, Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia, Journal of Endocrinology, 2012, 215, 3, 363

    CrossRef

  16. 16
    Alessandro Fanzani, Viviane M. Conraads, Fabio Penna, Wim Martinet, Molecular and cellular mechanisms of skeletal muscle atrophy: an update, Journal of Cachexia, Sarcopenia and Muscle, 2012, 3, 3, 163

    CrossRef

  17. 17
    Aaron Winter, Jacqueline MacAdams, Stéphanie Chevalier, Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia, Clinical Nutrition, 2012, 31, 5, 765

    CrossRef

  18. 18
    Melissa J. Puppa, James P. White, Kandy T. Velázquez, Kristen A. Baltgalvis, Shuichi Sato, John W. Baynes, James A. Carson, The effect of exercise on IL-6-induced cachexia in the Apc Min/+ mouse, Journal of Cachexia, Sarcopenia and Muscle, 2012, 3, 2, 117

    CrossRef

  19. 19
    Mary A. Honors, Kimberly P. Kinzig, The role of insulin resistance in the development of muscle wasting during cancer cachexia, Journal of Cachexia, Sarcopenia and Muscle, 2012, 3, 1, 5

    CrossRef

  20. 20
    Min Tian, Kara L. Kliewer, Michelle L. Asp, Michael B. Stout, Martha A. Belury, c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice, Molecular Nutrition & Food Research, 2011, 55, 2
  21. 21
    R A Murphy, E Yeung, V C Mazurak, M Mourtzakis, Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia, British Journal of Cancer, 2011, 105, 10, 1469

    CrossRef

  22. 22
    Roman Eisner, Cynthia Stretch, Thomas Eastman, Jianguo Xia, David Hau, Sambasivarao Damaraju, Russell Greiner, David S. Wishart, Vickie E. Baracos, Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites, Metabolomics, 2011, 7, 1, 25

    CrossRef

  23. 23
    Rachel A. Murphy, Marina Mourtzakis, Quincy S.C. Chu, Vickie E. Baracos, Tony Reiman, Vera C. Mazurak, Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy, Cancer, 2011, 117, 8
  24. 24
    Michelle L. Asp, Min Tian, Kara L. Kliewer, Martha A. Belury, Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia, Cancer Biology & Therapy, 2011, 12, 11, 957

    CrossRef

  25. 25
    Elisavet K. Tiaka, Anastassios C. Manolakis, Andreas N. Kapsoritakis, Spyros P. Potamianos, The implication of adiponectin and resistin in gastrointestinal diseases, Cytokine & Growth Factor Reviews, 2011, 22, 2, 109

    CrossRef

  26. 26
    Victoria C. Foletta, Lloyd J. White, Amy E. Larsen, Bertrand Léger, Aaron P. Russell, The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy, Pflügers Archiv - European Journal of Physiology, 2011, 461, 3, 325

    CrossRef

  27. 27
    Federica Sotgia, Ubaldo E Martinez-Outschoorn, Stephanos Pavlides, Anthony Howell, Richard G Pestell, Michael P Lisanti, Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment, Breast Cancer Research, 2011, 13, 4, 213

    CrossRef

  28. 28
    Tsai-Hua Chung, Mark Yen-Ping Kuo, Jen-Kun Chen, Dong-Ming Huang, YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis, International Journal of Cancer, 2011, 129, 9
  29. 29
    S. Herzig, Molekulare und metabolische Komponenten der Tumorkachexie, Der Gynäkologe, 2010, 43, 7, 559

    CrossRef

  30. 30
    Fabio Penna, Andrea Bonetto, Maurizio Muscaritoli, Domiziana Costamagna, Valerio Giacomo Minero, Gabriella Bonelli, Filippo Rossi Fanelli, Francesco Maria Baccino, Paola Costelli, Muscle atrophy in experimental cancer cachexia: Is the IGF-1 signaling pathway involved?, International Journal of Cancer, 2010, 127, 7